Berruti A - Search Results

1

Time to progression in metastatic breast cancer patients treated with epirubicin is not improved by the addition of either cisplatin or lonidamine: final results of a phase III study with a factorial design.

Berruti A, Bitossi R, Gorzegno G, Bottini A, Alquati P, De Matteis A, Nuzzo F, Giardina G, Danese S, De Lena M, Lorusso V, Farris A, Sarobba MG, DeFabiani E, Bonazzi G, Castiglione F, Bumma C, Moro G, Bruzzi P, Dogliotti L; Epirubicin-Lonidamine Group, Orbassano, Torino, Italy. Berruti A, et al. J Clin Oncol. 2002 Oct 15;20(20):4150-9. doi: 10.1200/JCO.2002.08.012. J Clin Oncol. 2002. PMID: 12377958 Clinical Trial.

2

Three years' experience with tropisetron in the control of nausea and vomiting in cisplatin-treated patients.

Dogliotti L, Antonacci RA, Pazè E, Ortega C, Berruti A, Faggiuolo R. Dogliotti L, et al. Among authors: berruti a. Drugs. 1992;43 Suppl 3:6-10. doi: 10.2165/00003495-199200433-00004. Drugs. 1992. PMID: 1380432 Clinical Trial.

3

Mediastinal non-seminomatous germ cell tumours: effectiveness of platinum, etoposide, bleomycin combination chemotherapy plus adjunctive surgery.

Berruti A, Borasio P, Pazè E, Mossetti C, Gorzegno G, Dogliotti L. Berruti A, et al. Eur J Cancer. 1992;28A(10):1773. doi: 10.1016/0959-8049(92)90096-k. Eur J Cancer. 1992. PMID: 1382498 No abstract available.

4

Favorable response of metastatic adrenocortical carcinoma to etoposide, adriamycin and cisplatin (EAP) chemotherapy. Report of two cases.

Berruti A, Terzolo M, Paccotti P, Veglio F, Pia A, Dogliotti L, Angeli A. Berruti A, et al. Tumori. 1992 Oct 31;78(5):345-8. doi: 10.1177/030089169207800512. Tumori. 1992. PMID: 1494808

5

Hypertriglyceridemia during long-term interferon-alpha therapy: efficacy of diet and gemfibrosil treatment. A case report.

Berruti A, Gorzegno G, Vitetta G, Tampellini M, Dogliotti L. Berruti A, et al. Tumori. 1992 Oct 31;78(5):353-5. doi: 10.1177/030089169207800515. Tumori. 1992. PMID: 1494811

6

Prevention of nausea and vomiting in cisplatin-treated patients by a selective 5-hydroxytryptamine (5-HT3) receptor antagonist, ICS 205-930.

Dogliotti L, Faggiuolo R, Berruti A, Antonacci RA, Ortega C, Lancranjan I. Dogliotti L, et al. Among authors: berruti a. Tumori. 1990 Dec 31;76(6):595-8. doi: 10.1177/030089169007600618. Tumori. 1990. PMID: 2284699 Clinical Trial.

7

Melatonin and human cancer.

Dogliotti L, Berruti A, Buniva T, Torta M, Bottini A, Tampellini M, Terzolo M, Faggiuolo R, Angeli A. Dogliotti L, et al. Among authors: berruti a. J Steroid Biochem Mol Biol. 1990 Dec 20;37(6):983-7. doi: 10.1016/0960-0760(90)90454-s. J Steroid Biochem Mol Biol. 1990. PMID: 2285610

8

Cytotoxic chemotherapy for adrenocortical carcinoma.

Dogliotti L, Berruti A, Pia A, Paccotti P, Alì A, Angeli A. Dogliotti L, et al. Among authors: berruti a. Minerva Endocrinol. 1995 Mar;20(1):105-9. Minerva Endocrinol. 1995. PMID: 7544429 Review.

9

Feasibility of the association of mitotane with etoposide, adriamycin and cisplatin combination chemotherapy in advanced adrenocortical cancer patients. Report on 7 cases.

Pia A, Berruti A, Terzolo M, Paccotti P, Letizia C, Dogliotti L, Angeli A. Pia A, et al. Among authors: berruti a. Ann Oncol. 1995 May;6(5):509-10. doi: 10.1093/oxfordjournals.annonc.a059224. Ann Oncol. 1995. PMID: 7669716 Free article. Clinical Trial. No abstract available.

10

Third-line chemotherapy with mitomycin C and lonidamine in advanced bladder cancer. Partial response in a patient with skin and lung metastases.

Berruti A, Gerbino A, Faggiuolo R, Rovero E, Dogliotti L. Berruti A, et al. Tumori. 1995 Jan-Feb;81(1):39-41. doi: 10.1177/030089169508100109. Tumori. 1995. PMID: 7754539

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

533 results

Search Page

Filters